Pilco Pharma Private Limited
Pilco Pharma Private Limited is a Private Indian company incorporated in 1988 and based in Uttar Pradesh, India. Pilco Pharma Private Limited operates in Pharmaceuticals & Chemicals (NIC 24231) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Explore the complete profile of Pilco Pharma Private Limited, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Pilco Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +13d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Pilco Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 674987980 | ICICI Bank Ltd(Bank) | ₹10.54 Cr | 12 Mar 2021 | Open |
| 670066494 | Kotak Mahindra Bank Ltd(Bank) | ₹8.62 Cr | 12 Mar 2021 | Open |
| 211436925 | HDFC Bank Ltd(Bank) | ₹15.29 Cr | 12 Mar 2021 | Satisfied |
| 940958309 | HDFC Bank Ltd(Bank) | ₹6.53 Cr | 04 Jul 2023 | Open |
Charge IDs, lenders & amounts for Pilco Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹6.12 Cr | ₹54.77 L | ₹4.26 Cr | ₹7.14 Cr | 225 |
| FY2023-24 | ₹5.27 Cr | ₹30.97 L | ₹2.49 Cr | ₹5.29 Cr | 149 |
| FY2022-23 | ₹3.99 Cr | ₹35.56 L | ₹2.91 Cr | ₹4.29 Cr | 94 |
| FY2021-22 | ₹4.95 Cr | ₹30.59 L | ₹2.67 Cr | ₹8.19 Cr | 229 |
Audited financials & ratios for Pilco Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹6.12 Cr | ₹5.27 Cr | ₹3.99 Cr | ₹4.95 Cr |
| Other income | ₹11.48 L | ₹18.16 L | ₹5.19 L | ₹9.46 L |
| Total income | ₹6.23 Cr | ₹5.45 Cr | ₹4.04 Cr | ₹5.04 Cr |
| Total expenses | ₹5.53 Cr | ₹5.06 Cr | ₹3.59 Cr | ₹4.65 Cr |
| Profit before tax | ₹71.20 L | ₹40.26 L | ₹46.23 L | ₹39.77 L |
| Profit / (Loss) after tax | ₹54.77 L | ₹30.97 L | ₹35.56 L | ₹30.59 L |
| Balance sheet | ||||
| Equity / Net worth | ₹4.26 Cr | ₹2.49 Cr | ₹2.91 Cr | ₹2.67 Cr |
| Borrowings | ₹1.10 Cr | ₹1.49 Cr | ₹71.94 L | ₹2.14 Cr |
| Current liabilities | ₹1.02 Cr | ₹87.78 L | ₹68.03 L | ₹1.67 Cr |
| Total liabilities | ₹2.88 Cr | ₹2.80 Cr | ₹1.38 Cr | ₹5.52 Cr |
| Current assets | ₹2.83 Cr | ₹2.99 Cr | ₹1.58 Cr | ₹4.29 Cr |
| Cash & equivalents | ₹74.63 L | ₹1.03 Cr | ₹63.11 L | ₹1.42 Cr |
| Total assets | ₹7.14 Cr | ₹5.29 Cr | ₹4.29 Cr | ₹8.19 Cr |
| Employees | 225 | 149 | 94 | 229 |
Audited financials & ratios for Pilco Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹6.12 Cr | +2.9% | +23.8% | +7.5% |
| Profit after Tax | ₹54.77 L | +34.0% | +11.1% | +3.2% |
| Net Worth | ₹4.26 Cr | +23.5% | +3.9% | +19.1% |
| Employees | 225 | -11.1% | +18.0% | +6.7% |
Audited financials & ratios for Pilco Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹6.12 Cr | ₹54.77 L | +8.95% | -12.38% | +12.86% | +7.67% | 0.26 | ₹2.72 L |
| FY2023-24 | ₹5.27 Cr | ₹30.97 L | +5.87% | -6.12% | +12.43% | +5.85% | 0.60 | ₹3.54 L |
| FY2022-23 | ₹3.99 Cr | ₹35.56 L | +8.91% | +25.53% | +12.22% | +8.30% | 0.25 | ₹4.24 L |
| FY2021-22 | ₹4.95 Cr | ₹30.59 L | +6.18% | +35.66% | +11.47% | +3.73% | 0.80 | ₹2.16 L |
Audited financials & ratios for Pilco Pharma Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,76,58,394 | 63.78% |
| Institutional Investors | 3 | 25,83,856 | 9.33% |
| Public & Others | 38 | 74,42,841 | 26.88% |
Promoter, institutional & public holding for Pilco Pharma Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
11 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.